Nexpoint Asset Management’s Boston Scientific BSX Stock Holding History

Nexpoint Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-33,500	Closed	-$1.42M	–	173
2021 Q4	$1.42M	Buy	+33,500	New	+$1.41M	0.2%	77
2021 Q2	–	Sell	-23,000	Closed	-$889K	–	174
2021 Q1	$889K	Hold	23,000	–	–	0.23%	65
2020 Q4	$827K	Hold	23,000	–	–	0.27%	83
2020 Q3	$879K	Hold	23,000	–	–	0.2%	84
2020 Q2	$808K	Hold	23,000	–	–	0.18%	83
2020 Q1	$750K	Buy	+23,000	New	+$899K	0.14%	100

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Nexpoint Asset Management's BSX Position: Q1 2022 in Review

Nexpoint Asset Management sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 33,500 shares — an estimated $1.42M sold.

Nexpoint Asset Management first reported a position in BSX in Q1 2020 and held it in 6 quarters. The position peaked at $1.42M in Q4 2021. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

Nexpoint Asset Management reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
Nexpoint Asset Management sold 33,500 Boston Scientific shares in Q1 2022, an estimated $1.42M.
Nexpoint Asset Management first reported a position in Boston Scientific in Q1 2020 and held it in 6 quarters.
Nexpoint Asset Management's Boston Scientific position peaked at $1.42M in Q4 2021.
904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Nexpoint Asset Management's 13F filing for Q1 2022, filed 16 May 2022.